Seeing Is Believing
MGTA is currently covered by 5 analysts with an average price target of $16.97. This is a potential upside of $3.75 (28.37%) from yesterday's end of day stock price of $13.22.
Magenta Therapeutics's activity chart (see below) currently has 14 price targets and 17 ratings on display. The stock rating distribution of MGTA is 85.71% BUY and 14.29% HOLD.
Analysts average stock forecasts to be materialized ratio is 25.93% with an average time for these price targets to be met of 80.44 days.
Highest price target for MGTA is $2, Lowest price target is $2, average price target is $16.97.
Most recent stock forecast was given by YUN ZHONG from BTIG on 26-Jan-2023. First documented stock forecast 16-Jul-2018.
Currently out of the existing stock ratings of MGTA, 6 are a BUY (85.71%), 1 are a HOLD (14.29%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
1 years 2 months 23 days ago
0/3 (0%)
$4.08 (212.50%)
Buy
1
$0.3 (42.86%)
9
1 years 2 months 23 days ago
0/4 (0%)
$0.56 (127.27%)
Hold
2
$1.3 (185.71%)
7
1 years 7 months 24 days ago
1/3 (33.33%)
$0.13 (6.95%)
14
Buy
8
$7.3 (1042.86%)
17
2 years ago
0/3 (0%)
$6.08 (316.67%)
Buy
8
$7.3 (1042.86%)
17
2 years 4 days ago
0/2 (0%)
$5.76 (257.14%)
What is MGTA (Magenta Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on MGTA (Magenta Therapeutics) with a proven track record?
Which analyst has the current lower performing score on MGTA (Magenta Therapeutics) with a proven track record?
Which analyst has the most public recommendations on MGTA (Magenta Therapeutics)?
Which analyst is the currently most bullish on MGTA (Magenta Therapeutics)?
Which analyst is the currently most reserved on MGTA (Magenta Therapeutics)?